Impact of Topical Fluocinonide on Oral Lichen Planus Evolution: Randomized Controlled Clinical Trial

Alessandro Polizzi,Gianluca Martino Tartaglia,Simona Santonocito,Angela Alibrandi,Anna Elisa Verzì,Gaetano Isola
DOI: https://doi.org/10.1111/odi.15156
2024-10-16
Oral Diseases
Abstract:Objective To examine the impact of fluocinonide 0.05% gel formulation for the topical treatment of oral lichen planus (OLP). Methods Through an RCT design, 47 patients with OLP were randomly allocated for topical OLP treatment with fluocinonide 0.05% (n = 23) or placebo (n = 24). Patients were examined for OLP symptoms, signs, disease severity, and extension score changes over 6‐month follow‐up. Results After 6 months, in comparison with placebo, patients treated with fluocinonide experienced a significant reduction of OLP symptoms (p = 0.024), signs (p = 0.014), and OLP extension score (p = 0.028). The two‐way ANOVA estimation models revealed that treatment with fluocinonide determined, at 6 months, a positive significant effect on the reduced OLP signs (p = 0.017), OLP symptoms (p = 0.026), and OLP extension score (p = 0.028). The multivariate regression analysis highlighted that anxiety, stress, and depression were significant predictors of every analyzed OLP outcome (p
dentistry, oral surgery & medicine
What problem does this paper attempt to address?